Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
1,254,222
-
Share change
-
+203,090
-
Total reported value
-
$11,446,000
-
Price per share
-
$9.10
-
Number of holders
-
11
-
Value change
-
+$1,872,100
-
Number of buys
-
7
-
Number of sells
-
3
Institutional Holders of GALMED PHARMACEUTICALS LTD - SHS (GLMD) as of Q3 2017
As of 30 Sep 2017,
GALMED PHARMACEUTICALS LTD - SHS (GLMD) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,254,222 shares.
The largest 10 holders included
683 Capital Management, LLC, Park West Asset Management LLC, GLG LLC, MORGAN STANLEY, P.A.W. CAPITAL CORP, SHEPHERD KAPLAN KROCHUK, LLC, CapWealth Advisors, LLC, WETHERBY ASSET MANAGEMENT INC, ACADIAN ASSET MANAGEMENT LLC, and JPMORGAN CHASE & CO.
This page lists
11
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.